Severity of Tauopathy and Beta-amyloidosis in Logopenic Variant Primary Progressive Aphasia in Individuals With or Without a History of Developmental Dyslexia
Salvatore Spina1, Zachary Miller1, Sevinc Jakab1, Margherita Tamagnini1, Maria Luisa Mandelli1, Lisa Kritikos1, Hieu Pham1, Siddarth Ramkrishnan1, Mia Lin1, Jaeyeon Kim2, Mercedes Paredes2, Howard Rosen1, Lea Grinberg3, William Seeley1, Bruce Miller1, Maria Luisa Gorno Tempini1
1Neurology, UCSF Memory and Aging Center, 2Neurology, UCSF-Weill Institute of Neuroscience, 3Laboratory Medicine and Pathology, Neurosciences, Mayo Clinic
Objective:
To assess differences in the severity of Alzheimer’s disease neuropathological changes in disease epicenters of patients with logopenic variant PPA (lvPPA) with a history of learning differences/developmental dyslexia (LD) versus lvPPA patients without such history (non-LD).
Background:
Learning differences and developmental dyslexia are overrepresented in the lvPPA population. It is not known whether a history of developmental differences is associated with a more severe phenotypic expression of Alzheimer’s disease pathology.
Design/Methods:
We quantified the cortical area fraction of phospho-tau immunohistochemistry (IHC) and beta-amyloid IHC in the angular gyrus and superior temporal gyrus of postmortem brains of 15 cases of lvPPA secondary to Alzheimer’s disease of which 9 non-LD cases (2 males and 7 females), and 6 LD cases (2 males and 4 females). Histological sections were digitally acquired, and foreground IHC-signal was automatically separated and thresholded to quantify the respective tau and beta-amyloid area fractions in each region.
Results:
There were no differences in the mean age at death between the two groups. Disease duration was longer in the LD group (10.7 ± 1.2 years) than in the non-LD group (8.1 ± 0.8 years), p=0.09. When corrected for sex, age at death and Apo E4 carrier status, the LD group showed higher tau pathology burden in the superior temporal gyrus compared to the non-LD group (0.91% ± 0.37, p = 0.03). No differences in tau pathology burden between the groups were observed in the angular gyrus (0.39% ±  0.41, p=0.37). There were no statistically significant differences in the area fraction of beta-amyloid between the two groups of patients in both the angular gyrus and the superior temporal gyrus.
Conclusions:

Our data suggest that patients with lvPPA secondary to Alzheimer’s disease and a history of developmental differences have higher tau-pathology burden in the superior temporal gyrus compared to lvPPA-AD patients without such history.

10.1212/WNL.0000000000216685
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.